Cargando…

Chemical Effect of Bisphenol A on Non-Alcoholic Fatty Liver Disease

Non-alcoholic fatty liver disease (NAFLD) is considered a predominant chronic liver disease worldwide and a component of metabolic syndrome. Due to its relationship with multiple organs, it is extremely complex to precisely define its pathogenesis as well as to set appropriate therapeutic and preven...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dallio, Marcello, Diano, Nadia, Masarone, Mario, Gravina, Antonietta Gerarda, Patanè, Vittorio, Romeo, Mario, Di Sarno, Rosa, Errico, Sonia, Nicolucci, Carla, Abenavoli, Ludovico, Scarpellini, Emidio, Boccuto, Luigi, Persico, Marcello, Loguercio, Carmelina, Federico, Alessandro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6747307/ https://www.ncbi.nlm.nih.gov/pubmed/31466361 http://dx.doi.org/10.3390/ijerph16173134

Ejemplares similares

The Bisphenol A Induced Oxidative Stress in Non-Alcoholic Fatty Liver Disease Male Patients: A Clinical Strategy to Antagonize the Progression of the Disease
por: Federico, Alessandro, et al.
Publicado: (2020)

Nutrigenomics and Nutrigenetics in Metabolic- (Dysfunction) Associated Fatty Liver Disease: Novel Insights and Future Perspectives
por: Dallio, Marcello, et al.
Publicado: (2021)

Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver Disease
por: Masarone, Mario, et al.
Publicado: (2018)

Vascular Endothelial Dysfunction in Inflammatory Bowel Diseases: Pharmacological and Nonpharmacological Targets
por: Gravina, Antonietta Gerarda, et al.
Publicado: (2018)

Corrigendum to “Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver Disease”
por: Masarone, Mario, et al.
Publicado: (2021)

Evaluation of the Effect Derived from Silybin with Vitamin D and Vitamin E Administration on Clinical, Metabolic, Endothelial Dysfunction, Oxidative Stress Parameters, and Serological Worsening Markers in Nonalcoholic Fatty Liver Disease Patients
por: Federico, Alessandro, et al.
Publicado: (2019)

Ameliorative effect of Silybin on bisphenol A induced oxidative stress, cell proliferation and steroid hormones oxidation in HepG2 cell cultures
por: Lama, Stefania, et al.
Publicado: (2019)

Qualitative and Quantitative Evaluation of Dietary Intake in Patients with Non-Alcoholic Steatohepatitis
por: Federico, Alessandro, et al.
Publicado: (2017)

Adherence and Effects Derived from FODMAP Diet on Irritable Bowel Syndrome: A Real Life Evaluation of a Large Follow-Up Observation
por: Gravina, Antonietta Gerarda, et al.
Publicado: (2020)

Coeliac disease and C virus-related chronic hepatitis: a non association
por: Gravina, Antonietta Gerarda, et al.
Publicado: (2012)

PNPLA3, TM6SF2, and MBOAT7 Influence on Nutraceutical Therapy Response for Non-alcoholic Fatty Liver Disease: A Randomized Controlled Trial
por: Dallio, Marcello, et al.
Publicado: (2021)

Diet and Non-Alcoholic Fatty Liver Disease: The Mediterranean Way
por: Abenavoli, Ludovico, et al.
Publicado: (2019)

Carcinogenesis as a Result of Multiple Inflammatory and Oxidative Hits: a Comprehensive Review from Tumor Microenvironment to Gut Microbiota
por: Morgillo, Floriana, et al.
Publicado: (2018)

Just Drink a Glass of Water? Effects of Bicarbonate–Sulfate–Calcium–Magnesium Water on the Gut–Liver Axis
por: Gravina, Antonietta Gerarda, et al.
Publicado: (2022)

The Role of Fructose in Non-Alcoholic Steatohepatitis: Old Relationship and New Insights
por: Federico, Alessandro, et al.
Publicado: (2021)

Rapid Virological Response Represents the Highest Prediction Factor of Response to Antiviral Treatment in HCV-Related Chronic Hepatitis: a Multicenter Retrospective Study
por: Federico, Alessandro, et al.
Publicado: (2015)

NAFLD and Extra-Hepatic Comorbidities: Current Evidence on a Multi-Organ Metabolic Syndrome
por: Rosato, Valerio, et al.
Publicado: (2019)

Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years
por: Federico, Alessandro, et al.
Publicado: (2017)

Human Genes Involved in the Interaction between Host and Gut Microbiome: Regulation and Pathogenic Mechanisms
por: Boccuto, Luigi, et al.
Publicado: (2023)

Skin Adverse Events During Dual and Triple Therapy for HCV-Related Cirrhosis
por: Federico, Alessandro, et al.
Publicado: (2014)

A 60-Year-Old Woman with Primary Biliary Cholangitis and Crohn’s Ileitis Following the Suspension of Ursodeoxycholic Acid
por: Romeo, Mario, et al.
Publicado: (2022)

Immunity as Cornerstone of Non-Alcoholic Fatty Liver Disease: The Contribution of Oxidative Stress in the Disease Progression
por: Dallio, Marcello, et al.
Publicado: (2021)

The Role of Resveratrol in Liver Disease: A Comprehensive Review from In Vitro to Clinical Trials
por: Izzo, Carmine, et al.
Publicado: (2021)

Ultrasound Prevalence and Clinical Features of Nonalcoholic Fatty Liver Disease in Patients with Inflammatory Bowel Diseases: A Real-Life Cross-Sectional Study
por: Abenavoli, Ludovico, et al.
Publicado: (2023)

Gut Microbiota in Non-Alcoholic Fatty Liver Disease Patients with Inflammatory Bowel Diseases: A Complex Interplay
por: Abenavoli, Ludovico, et al.
Publicado: (2022)

Gut Microbiota and Liver Transplantation: Immune Mechanisms behind the Rejection
por: Abenavoli, Ludovico, et al.
Publicado: (2023)

Dietary Polyphenols and Non-Alcoholic Fatty Liver Disease
por: Abenavoli, Ludovico, et al.
Publicado: (2021)

Helicobacter pylori and extragastric diseases: A review
por: Gravina, Antonietta Gerarda, et al.
Publicado: (2018)

Safety and efficacy of sorafenib in patients with advanced hepatocellular carcinoma and Child-Pugh A or B cirrhosis
por: FEDERICO, ALESSANDRO, et al.
Publicado: (2015)

Regorafenib in combination with silybin as a novel potential strategy for the treatment of metastatic colorectal cancer
por: Belli, Valentina, et al.
Publicado: (2017)

Secondary Extramedullary Plasmacytoma of the Duodenum: An Unusual Endoscopic Presentation
por: Gravina, Antonietta Gerarda, et al.
Publicado: (2013)

The Melanocortin System in Inflammatory Bowel Diseases: Insights into Its Mechanisms and Therapeutic Potentials
por: Gravina, Antonietta Gerarda, et al.
Publicado: (2023)

Current Status and Future Therapeutic Options for Fecal Microbiota Transplantation
por: Tkach, Sergii, et al.
Publicado: (2022)

Metabolic-Dysfunction-Associated Fatty Liver Disease and Gut Microbiota: From Fatty Liver to Dysmetabolic Syndrome
por: Abenavoli, Ludovico, et al.
Publicado: (2023)

Gut Microbiota and Critically Ill Patients: Immunity and Its Modulation via Probiotics and Immunonutrition
por: Abenavoli, Ludovico, et al.
Publicado: (2023)

Viral hepatitis: Milestones, unresolved issues, and future goals
por: Torre, Pietro, et al.
Publicado: (2021)

Country-Wide HCV Elimination Strategies Need to Reach Older Patients in the General Population: The Italian Experience
por: Torre, Pietro, et al.
Publicado: (2023)

From Non-Alcoholic Steatohepatitis (NASH) to Hepatocellular Carcinoma (HCC): Epidemiology, Incidence, Predictions, Risk Factors, and Prevention
por: Motta, Benedetta Maria, et al.
Publicado: (2023)

Gut microbiota correlates with antitumor activity in patients with mCRC and NSCLC treated with cetuximab plus avelumab
por: Martini, Giulia, et al.
Publicado: (2022)

A New LC-MS/MS Method for Simultaneous and Quantitative Detection of Bisphenol-A and Steroids in Target Tissues: A Power Tool to Characterize the Interference of Bisphenol-A Exposure on Steroid Levels
por: Errico, Sonia, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_c5ktsf8sgod5aua8tble2q64hn